TrialSiteNews

Join The Conversation! | https://trialsitenews.com/ University of Arkansas' Dr. Jorge Almodovar, assistant professor of chemical engineering and Dr. Raj Rao, professor and head of the Department of Biomedical Engineering, discuss their new research grant from the National Science Foundation to study how engineered coatings that imitiate the tissue matrix would affect human mesenchymal stromal cells (hMSCSs) and why that can be helpful to treating many diseases. Link | https://news.uark.edu/articles/56592/researchers-receive-grant-to-improve-cellular-therapies-to-treat-incurable-diseases

Sonia Elijah interviews My interview with Prof Norman Fenton was highly revealing you can watch it here. Fenton, who has a PhD in Mathematics, is professor of Risk Information Management at Queen Mary, University of London. He co-authored a paper along with eight others including: Martin Neil, Jessica Rose, Clare Craig, Jonathan Engler, Joel Smalley, Scott Mclachlan, Joshua Guetzkow and Dan Russell. The paper, entitled, ‘Official mortality data for England suggest systematic miscategorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination’ was published early December 2021, as a preprint on ResearchGate. Their paper was an in-depth analysis of the UK ONS report, ‘Deaths involving Covid-19 by vaccination status, England: deaths occurring between 2 January and 24 September 2021.’

Dr. Dan Mishmar and PhD candidate Hadar Medini discuss their recent research on the mitochondria and COVID-19. Is COVID-19 more of a mitochondria dysfunction than a respiratory disease? This podcast interview is based on their peer-reviewed, published paper: Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. ( https://www.sciencedirect.com/science/article/pii/S2589004221014425) Dr. Mishmar, a professor, geneticist and evolutionist, runs his own lab (Mishmar Lab) at Ben-Gurion University in Israel. (https://lifewp.bgu.ac.il/wp/dmishmar/)

Join The Conversation! | https://trialsitenews.com/ Dr. Dan Mishmar and PhD candidate Hadar Medini discuss their recent research on the mitochondria and COVID-19. Is COVID-19 more of a mitochondria dysfunction than a respiratory disease? This interview is based on their peer-reviewed, published paper: Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. Link | https://www.sciencedirect.com/science/article/pii/S2589004221014425 Dr. Mishmar, a professor, geneticist and evolutionist, runs his own lab (Mishmar Lab) at Ben-Gurion University in Israel. Link | https://lifewp.bgu.ac.il/wp/dmishmar/

What makes Geert Vanden Bossche make statements about the current corona crisis? Does he have the right to speak? What is his background?

Suppose you've had your 2 doses of vaccines. Those clearly don't stop the SARS-CoV-2 virus. So what should you do? An additional booster? Do you get a different effect with more of the same? And is a specific omicron booster a good idea? Geert Vanden Bossche, virologist and vaccinologist, provides clarification and advice.

Steven Goh is CEO of Achiko, a mobile health technology company creating new rapid tests for COVID-19 and more. To learn more visit the link | https://www.achiko.com/team/steven-goh

Join The Conversation! | https://trialsitenews.com/ Steven Goh is CEO of Achiko, a mobile health technology company creating new rapid tests for COVID-19 and more. To learn more click here | https://www.achiko.com/team/steven-goh

Voice For Science And Solidarity Interview with Dr. Geert Vanden Bossche Part 1 | Dr. Geert Weighs In On The Question Should We Vaccinate Children? As a parent you are faced with an important but oh so difficult choice, namely whether or not to vaccinate your child. And what is the right thing to do? Geert Vanden Bossche, virologist and vaccinologist, provides clarification and advice.

Join The Conversation! | https://trialsitenews.com/ Dr. Niko Andre, MD, PhD and Global Franchise Head of Hematology and Immuno Oncology at AstraZeneca discusses new clinical trial information for CALQUENCE, a drug used to treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL). You can learn more about CALQUENCE here: Link | https://www.calquence.com

Join The Conversation! | https://trialsitenews.com/ Dr. Niko Andre, MD, PhD and Global Franchise Head of Hematology and Immuno Oncology at AstraZeneca discusses new clinical trial information for CALQUENCE, a drug used to treat Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL). You can learn more about CALQUENCE here: Link | https://www.calquence.com

Join The Conversation! | https://trialsitenews.com/ Story 01 | Proposed California Bill: Children Aged 12 & Up Could Get COVID-19 Vaccine without Parental Knowledge Soon, California kids aged 12 and up could receive a COVID-19 vaccine without even telling their parents if a new legislative bill is successful. Sen. Scott Weiner (D: San Francisco) introduced Senate Bill 866 recently to enable this controversial option, one which many would consider a blatant state-level intrusion into family life. Link | https://trialsitenews.com/proposed-california-bill-children-aged-12-up-could-get-covid-19-vaccine-without-parental-knowledge/ Story 02 | 79,000+ Australians Filing Compensation Claims for COVID-19 Vaccine Injuries Australia now is compensating COVID-19 vaccine patients for serious adverse events. Australian news reports that the COVID-19 vaccines have led to at least 79,000 adverse reactions. Those patients claiming under $20,000 must provide evidence from their physician. For those with more serious conditions leading to claims over $20,000, they require a review by a panel of legal experts. More nations are acknowledging that these vaccines can lead to injury and that those injured should be compensated. Link | https://trialsitenews.com/79000-australians-filing-compensation-claims-for-covid-19-vaccine-injuries/

Join The Conversation! | https://trialsitenews.com/ Story 01 | Proposed California Bill: Children Aged 12 & Up Could Get COVID-19 Vaccine without Parental Knowledge Soon, California kids aged 12 and up could receive a COVID-19 vaccine without even telling their parents if a new legislative bill is successful. Sen. Scott Weiner (D: San Francisco) introduced Senate Bill 866 recently to enable this controversial option, one which many would consider a blatant state-level intrusion into family life. Link | https://trialsitenews.com/proposed-california-bill-children-aged-12-up-could-get-covid-19-vaccine-without-parental-knowledge/ Story 02 | 79,000+ Australians Filing Compensation Claims for COVID-19 Vaccine Injuries Australia now is compensating COVID-19 vaccine patients for serious adverse events. Australian news reports that the COVID-19 vaccines have led to at least 79,000 adverse reactions. Those patients claiming under $20,000 must provide evidence from their physician. For those with more serious conditions leading to claims over $20,000, they require a review by a panel of legal experts. More nations are acknowledging that these vaccines can lead to injury and that those injured should be compensated. Link | https://trialsitenews.com/79000-australians-filing-compensation-claims-for-covid-19-vaccine-injuries/

Join The Conversation! | https://trialsitenews.com/ Dr. David Ostrov PhD is an immunologist at the University of Florida who works in the pathology laboratories. His research team focuses on structure-based drug design to discover novel therapies for preventing and treating diseases. He's recently done research on how repurposed drugs and cheap drug combinations might prevent and/or treat COVID-19. You can learn more about his work and contact him through his lab here: Link | https://pathlabs.ufl.edu/about-us/pathologists/experimental-pathology/drug-discovery/david-a-ostrov-phd/

Dr. David Ostrov PhD is an immunologist at the University of Florida who works in the pathology laboratories. His research team focuses on structure-based drug design to discover novel therapies for preventing and treating diseases.He's recently done research on how repurposed drugs and cheap drug combinations can prevent and/or treat COVID-19. You can learn more about his work and contact him through his lab here: https://pathlabs.ufl.edu/about-us/pathologists/experimental-pathology/drug-discovery/david-a-ostrov-phd/

Join The Conversation! | https://trialsitenews.com/ Medable Inc is a leading platform for patient-centered clinical research and just announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials. Dr. Pamela Tenaerts , chief scientific officer and Sanskriti Thakur , chief growth officer, discuss how Medable is innovating the world of decentralized clinical trials.

Join The Conversation! | https://trialsitenews.com/ Medable Inc is a leading platform for patient-centered clinical research and just announced $304 million in Series D funding to accelerate global adoption of digital and decentralized clinical trials. Dr. Pamela Tenaerts , chief scientific officer and Sanskriti Thakur , chief growth officer, discuss how Medable is innovating the world of decentralized clinical trials.

TrialSite News presents a riveting episode of CATalyst with Shabnam Palesa Mohamed, and special guests Dr Shankara Chetty and Omar Khan. Find out what priorities are key for health and science in 2022, what could be causing cancer and prions disease post jab, what the real impact of conflicts of interest and censorship are, why Chetty and Khan call for an equitable way to access medicines that benefit people over astronomical profits, and why they believe that 'civil disobedience' is necessary to end the lockdown. Dr Shankara Chetty: Medical Doctor and Biological Scientist with over 30 years experience in Rural and Remote Primary Care. C19 expert physician. (South Africa). Omar Khan: Leadership development consultant developing corporate leaders and facilitators around the world. He is an author, speaker and researcher. (Sri Lanka/USA). Saturday 15 January 2022. #TrialSiteNews #CATalyst #SouthToNorth #HealthMatters

Join The Conversation! | https://trialsitenews.com/ Story 1 | NCAA To Exempt Athletes Who Have Been Infected By Covid-19 The nation’s largest collegiate sports organization, the National Collegiate Athletic Association, or NCAA, issued new guidance last week exempting student-athletes and coaching staff who have been infected with COVID-19 within 90 days from vaccination mandates. Student-athletes with COVID-19 infections are exempt from vaccine mandates. Link | https://trialsitenews.com/ncaa-athletes-with-natural-immunity-are-fully-vaccinated/ Story 2 | Fully Vaccinated Cases Skyrocket In Scotland Fully vaccinated persons in Scotland are now hospitalized at greater levels than ever, with an ever-growing number of the elderly becoming seriously ill because of vaccine durability issues. Link | https://trialsitenews.com/who-said-this-was-a-pandemic-of-the-unvaccinated-fully-vaxxed-cass-skyrocket-past-unvaxxed-in-scotland/

Join The Conversation! | https://trialsitenews.com/ Founded by Chinese biotech entrepreneur Wei William Cao, Suzhou, China headquartered Gracell Biotechnologies Co., Ltd (Gracell) is on a mission to bring best-in-class and economical cellular medicines to cancer patients. Dedicating capital, talent, and technology to resolve the cellular gene therapy industry’s major challenges including high production costs, lengthy manufacturing process, lack of off-the-shelf products, and short duration of therapeutic effects, the global clinical-stage biopharmaceutical company leverages its pioneering FastCAR and TruUCAR technology platforms. The company recently reported good news: its investigational treatment for multiple myeloma known as GCO12F has been assigned orphan drug status by the U.S. Food and Drug Administration (FDA).

Join The Conversation! | https://trialsitenews.com/ Story 1 | NCAA To Exempt Athletes Who Have Been Infected By Covid-19 The nation’s largest collegiate sports organization, the National Collegiate Athletic Association, or NCAA, issued new guidance last week exempting student-athletes and coaching staff who have been infected with COVID-19 within 90 days from vaccination mandates. Student-athletes with COVID-19 infections are exempt from vaccine mandates. Link | https://trialsitenews.com/ncaa-athletes-with-natural-immunity-are-fully-vaccinated/ Story 2 | Fully Vaccinated Cases Skyrocket In Scotland Fully vaccinated persons in Scotland are now hospitalized at greater levels than ever, with an ever-growing number of the elderly becoming seriously ill because of vaccine durability issues. Link | https://trialsitenews.com/who-said-this-was-a-pandemic-of-the-unvaccinated-fully-vaxxed-cass-skyrocket-past-unvaxxed-in-scotland/

Join The Conversation! | https://trialsitenews.com/ Founded by Chinese biotech entrepreneur Wei William Cao, Suzhou, China headquartered Gracell Biotechnologies Co., Ltd (Gracell) is on a mission to bring best-in-class and economical cellular medicines to cancer patients. Dedicating capital, talent, and technology to resolve the cellular gene therapy industry’s major challenges including high production costs, lengthy manufacturing process, lack of off-the-shelf products, and short duration of therapeutic effects, the global clinical-stage biopharmaceutical company leverages its pioneering FastCAR and TruUCAR technology platforms. The company recently reported good news: its investigational treatment for multiple myeloma known as GCO12F has been assigned orphan drug status by the U.S. Food and Drug Administration (FDA).

Join The Conversation! | https://trialsitenews.com/ Dr. Robert Louis, Chief of Neurosurgery and the Empower360 Endowed Chair for Skull Base and Minimally Invasive Neurosurgery at Hoag, is a champion for virtual reality and has led the charge on bringing innovative treatment options to Hoag patients. He recently helped open the new Hoag Center for Advanced Visualization and Immersive Therapeutics - or XR Lab for short - where physicians are researching, developing and deploying the newest XR technologies.

Join The Conversation! | https://trialsitenews.com/ Dr. Robert Louis, Chief of Neurosurgery and the Empower360 Endowed Chair for Skull Base and Minimally Invasive Neurosurgery at Hoag, is a champion for virtual reality and has led the charge on bringing innovative treatment options to Hoag patients. He recently helped open the new Hoag Center for Advanced Visualization and Immersive Therapeutics - or XR Lab for short - where physicians are researching, developing and deploying the newest XR technologies.

Join The Conversation! | https://trialsitenews.com/ Jeffrey R. Holt, Ph.D. is a professor of otolaryngology & neurology, director of research, otolaryngology at the F.M. Kirby Neurobiology Center, Boston Children's Hospital and is on the Harvard Medical School and Harvard-MIT Health Sciences Technology Faculty. You can read his paper in Science Advances here: Links | https://www.science.org/doi/10.1126/sciadv.abi7629